Michael Giannis

Title: Michael Giannis: Innovator in Dendrimer-Drug Conjugates

Introduction

Michael Giannis is a notable inventor based in Point Cook, Australia. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on dendrimer-drug conjugates. His research focuses on the development of macromolecules that can enhance therapeutic applications.

Latest Patents

Michael Giannis holds 1 patent related to his invention of dendrimer-drug conjugates. This invention pertains to macromolecules that consist of a pharmaceutically active agent, such as a protein or peptide, which is attached to a core of a dendrimer derived from branched building units like lysine or its analogues. The patent also covers the synthesis of these dendrimers and macromolecules, along with their use in therapeutic applications and pharmaceutical compositions.

Career Highlights

Michael Giannis is associated with Starpharma Pty Limited, where he continues to advance his research and development efforts. His work has the potential to significantly impact the pharmaceutical industry by providing new avenues for drug delivery and therapeutic efficacy.

Collaborations

Michael collaborates with esteemed colleagues, including David James Owen and Pauline Stanislawski. Their combined expertise contributes to the innovative research environment at Starpharma Pty Limited.

Conclusion

Michael Giannis is a pioneering inventor whose work on dendrimer-drug conjugates exemplifies the intersection of innovation and pharmaceutical science. His contributions are poised to make a lasting impact on therapeutic applications and drug development.